These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16700798)

  • 1. Vitiligo: auto-immunity and immune responses.
    Sehgal VN; Srivastava G
    Int J Dermatol; 2006 May; 45(5):583-90. PubMed ID: 16700798
    [No Abstract]   [Full Text] [Related]  

  • 2. Physiopathology and genetics of vitiligo.
    Passeron T; Ortonne JP
    J Autoimmun; 2005; 25 Suppl():63-8. PubMed ID: 16298511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re: Vitiligo: auto-immunity and immune responses.
    Ansari N
    Int J Dermatol; 2007 Dec; 46(12):1314-5. PubMed ID: 18173536
    [No Abstract]   [Full Text] [Related]  

  • 4. Autoimmunity as an aetiological factor in vitiligo.
    Rezaei N; Gavalas NG; Weetman AP; Kemp EH
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):865-76. PubMed ID: 17658994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The genetics of generalized vitiligo and associated autoimmune diseases.
    Spritz RA
    J Dermatol Sci; 2006 Jan; 41(1):3-10. PubMed ID: 16289692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vitiligo and other endocrine complications with an autoimmune basis].
    Herrera Pombo JL; Rodríguez ME; Rovira A; Martínez J; Salvador ML; Pérez Naranjo JM; de Castro A; Orbaneja JG
    Rev Clin Esp; 1982 Dec; 167(5):321-5. PubMed ID: 6897748
    [No Abstract]   [Full Text] [Related]  

  • 7. [Association of the HLA system with vitiligo].
    Minev M; Tonkin N; Martinova F
    Vestn Dermatol Venerol; 1985 May; (5):41-2. PubMed ID: 3875946
    [No Abstract]   [Full Text] [Related]  

  • 8. Modern genetics, ancient defenses, and potential therapies.
    Gregersen PK
    N Engl J Med; 2007 Mar; 356(12):1263-6. PubMed ID: 17377166
    [No Abstract]   [Full Text] [Related]  

  • 9. Congenital stable symmetrical type vitiligo in a patient whose mother developed vitiligo during pregnancy.
    Kedward AL; Gawkrodger DJ
    Eur J Dermatol; 2008; 18(3):353. PubMed ID: 18515208
    [No Abstract]   [Full Text] [Related]  

  • 10. [Vitiligo: nothing new?].
    Naeyaert JM; Ongenae K; Van Geel N
    Ann Dermatol Venereol; 2003 Mar; 130(3):309-11. PubMed ID: 12746664
    [No Abstract]   [Full Text] [Related]  

  • 11. Unraveling the complex relationship between cancer immunity and autoimmunity: lessons from melanoma and vitiligo.
    Uchi H; Stan R; Turk MJ; Engelhorn ME; Rizzuto GA; Goldberg SM; Wolchok JD; Houghton AN
    Adv Immunol; 2006; 90():215-41. PubMed ID: 16730265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitiligo: pathomechanisms and genetic polymorphism of susceptible genes.
    Shajil EM; Chatterjee S; Agrawal D; Bagchi T; Begum R
    Indian J Exp Biol; 2006 Jul; 44(7):526-39. PubMed ID: 16872041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibody responses to melanocytes in the depigmenting skin disease vitiligo.
    Kemp EH; Gavalas NG; Gawkrodger DJ; Weetman AP
    Autoimmun Rev; 2007 Jan; 6(3):138-42. PubMed ID: 17289548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The PTPN22-1858C>T (R620W) functional polymorphism is associated with generalized vitiligo in the Romanian population.
    Laberge GS; Birlea SA; Fain PR; Spritz RA
    Pigment Cell Melanoma Res; 2008 Apr; 21(2):206-8. PubMed ID: 18426414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The analysis of genetics and associated autoimmune diseases in Chinese vitiligo patients.
    Zhang Z; Xu SX; Zhang FY; Yin XY; Yang S; Xiao FL; Du WH; Wang JF; Lv YM; Tang HY; Zhang XJ
    Arch Dermatol Res; 2009 Feb; 301(2):167-73. PubMed ID: 18839195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of interferon-gamma and tumor necrosis factor alpha polymorphisms with susceptibility to vitiligo in Iranian patients.
    Namian AM; Shahbaz S; Salmanpoor R; Namazi MR; Dehghani F; Kamali-Sarvestani E
    Arch Dermatol Res; 2009 Jan; 301(1):21-5. PubMed ID: 18820938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The autoimmune regulator gene (AIRE) is strongly associated with vitiligo.
    Tazi-Ahnini R; McDonagh AJ; Wengraf DA; Lovewell TR; Vasilopoulos Y; Messenger AG; Cork MJ; Gawkrodger DJ
    Br J Dermatol; 2008 Sep; 159(3):591-6. PubMed ID: 18616774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Narrow-band ultraviolet B phototherapy for the treatment of vitiligo: evidence against an autoimmune pathogenesis.
    Engin B; Baysal I; Reisli I; Ozdemir M; Toy H
    J Eur Acad Dermatol Venereol; 2008 Dec; 22(12):1520-1. PubMed ID: 18355207
    [No Abstract]   [Full Text] [Related]  

  • 19. Absence of tyrosinase-related protein-2/dopachrome tautomerase transcripts in PBMCs from vitiligo patients.
    Bam M; Bagchi T
    Scand J Immunol; 2009 Apr; 69(4):366-73. PubMed ID: 19284502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of genetic association of promoter and structural variants of mannan-binding lectin (MBL2) gene with susceptibility to generalized vitiligo.
    Dwivedi M; Gupta K; Gulla KC; Laddha NC; Hajela K; Begum R
    Br J Dermatol; 2009 Jul; 161(1):63-9. PubMed ID: 19416237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.